Jefferies raised its price target on Buy-rated Onyx Pharmaceuticals (NASDAQ: ONXX) from $96 to $104 after front-line Kyprolis survey data ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE